Published in BMC Cardiovasc Disord on December 22, 2009
Relationship between dyslipidemia and carotid plaques in a high-stroke-risk population in Shandong Province, China. Brain Behav (2016) 1.39
Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke (2012) 1.13
Predictors of carotid thickness and plaque progression during a decade: the Multi-Ethnic Study of Atherosclerosis. Stroke (2014) 1.06
The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study. Neurol Res (2011) 0.87
Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation. Blood (2015) 0.85
Ideal Cardiovascular Health and Cognitive Aging in the Northern Manhattan Study. J Am Heart Assoc (2016) 0.83
Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study. Stroke (2013) 0.83
Carotid intima-media thickness and apolipoproteins in patients of ischemic stroke in a rural hospital setting in central India: A cross-sectional study. J Neurosci Rural Pract (2012) 0.80
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease? J Lipid Res (2015) 0.79
Genetic susceptibility to cerebrovascular disease. Curr Opin Lipidol (2016) 0.76
Infectious Burden and Cognitive Decline in the Northern Manhattan Study. J Am Geriatr Soc (2015) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med (2005) 15.18
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ (2003) 11.21
The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data. Am J Prev Med (1988) 7.67
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74
Antiinflammatory properties of HDL. Circ Res (2004) 5.41
Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke (2001) 4.07
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation (1995) 3.82
Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol (2001) 2.89
High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA (2001) 2.85
Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70
Endothelial and antithrombotic actions of HDL. Circ Res (2006) 2.68
Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke (2003) 2.45
Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke (2004) 2.41
The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. J Intern Med (2006) 2.29
Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology (2008) 2.09
Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke (2002) 1.94
Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med (2004) 1.79
Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology (2004) 1.72
Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke (2003) 1.58
Elevated white blood cell count and carotid plaque thickness : the northern manhattan stroke study. Stroke (2001) 1.58
Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol (2004) 1.44
High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis (2007) 1.30
Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan Stroke Study. Neuroepidemiology (1999) 1.29
Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke (2006) 1.25
Lipid levels and the risk of ischemic stroke in women. Neurology (2007) 1.23
Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Vasc Health Risk Manag (2007) 1.15
Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. Stroke (2008) 1.11
Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke (1998) 1.10
Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study). Am J Cardiol (2007) 1.06
Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population. Arterioscler Thromb Vasc Biol (2002) 1.05
Relevance of common carotid intima-media thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. AJNR Am J Neuroradiol (2007) 0.99
Diabetes and cardiovascular disease. Is there a true Hispanic paradox? Rev Invest Clin (2004) 0.96
Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Vasc Biol (1997) 0.94
High-density lipoprotein metabolism: potential therapeutic targets. Am J Cardiol (2007) 0.94
ApoB/ApoA1 ratio and subclinical atherosclerosis. Int Angiol (2008) 0.89
The role of lipoprotein[a] in atherosclerosis. Curr Atheroscler Rep (2000) 0.86
Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area. Arterioscler Thromb Vasc Biol (2008) 0.86
Statins and stroke. Curr Med Chem (2008) 0.82
Role of hyperlipidemia in atherosclerotic plaque formation in the internal carotid artery. J Clin Ultrasound (2006) 0.82
Rate nephelometric assay of serum lipoprotein(a). Clin Chem (1993) 0.81
Role of lipid and lipoprotein metabolizing enzymes in the development of atherosclerosis. Indian J Exp Biol (2003) 0.80
Lipid composition in atheromatous plaque: evaluation of the lipid three-phase percentage. Life Sci (2003) 0.77
Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio. Atherosclerosis (2007) 0.77
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation (2002) 4.69
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA (2012) 3.67
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51
Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med (2012) 3.50
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation (2005) 3.25
Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke (2008) 3.21
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke (2007) 2.55
Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke (2005) 2.51
Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48
Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke (2003) 2.45
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44
Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
Stroke in the young in the northern Manhattan stroke study. Stroke (2002) 2.37
Patent foramen ovale and stroke. Circulation (2005) 2.34
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34
Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol (2005) 2.34
Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J (2006) 2.22
Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17
Left ventricular mass and geometry and the risk of ischemic stroke. Stroke (2003) 2.15
Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol (2007) 2.15
Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13
Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol (2009) 2.08
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06
Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke (2006) 2.05
Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00
Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97
Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke (2007) 1.96
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke (2002) 1.94
Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke (2005) 1.91
Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke (2008) 1.91
Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation (2012) 1.87
Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. J Am Coll Cardiol (2008) 1.85
Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke (2013) 1.80
Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77
Infectious burden and cognitive function: the Northern Manhattan Study. Neurology (2013) 1.77
Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol (2009) 1.74